These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 10698186

  • 21. Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5.
    Arai T, Arai A, Busby WH, Clemmons DR.
    Endocrinology; 1994 Dec; 135(6):2358-63. PubMed ID: 7527332
    [Abstract] [Full Text] [Related]

  • 22. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.
    Booth BA, Boes M, Andress DL, Dake BL, Kiefer MC, Maack C, Linhardt RJ, Bar K, Caldwell EE, Weiler J.
    Growth Regul; 1995 Mar; 5(1):1-17. PubMed ID: 7538367
    [Abstract] [Full Text] [Related]

  • 23. Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action.
    Allan GJ, Tonner E, Szymanowska M, Shand JH, Kelly SM, Phillips K, Clegg RA, Gow IF, Beattie J, Flint DJ.
    Endocrinology; 2006 Jan; 147(1):338-49. PubMed ID: 16195401
    [Abstract] [Full Text] [Related]

  • 24. Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I binding.
    Campbell PG, Andress DL.
    Am J Physiol; 1997 Nov; 273(5):E1005-13. PubMed ID: 9374688
    [Abstract] [Full Text] [Related]

  • 25. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells.
    Andress DL.
    J Biol Chem; 1995 Nov 24; 270(47):28289-96. PubMed ID: 7499327
    [Abstract] [Full Text] [Related]

  • 26. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions.
    Imai Y, Moralez A, Andag U, Clarke JB, Busby WH, Clemmons DR.
    J Biol Chem; 2000 Jun 16; 275(24):18188-94. PubMed ID: 10766744
    [Abstract] [Full Text] [Related]

  • 27. Scatter factor binds to thrombospondin and other extracellular matrix components.
    Lamszus K, Joseph A, Jin L, Yao Y, Chowdhury S, Fuchs A, Polverini PJ, Goldberg ID, Rosen EM.
    Am J Pathol; 1996 Sep 16; 149(3):805-19. PubMed ID: 8780385
    [Abstract] [Full Text] [Related]

  • 28. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain.
    Twigg SM, Kiefer MC, Zapf J, Baxter RC.
    J Biol Chem; 1998 Oct 30; 273(44):28791-8. PubMed ID: 9786878
    [Abstract] [Full Text] [Related]

  • 29. Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/42 mitogen-activated protein kinase.
    Martin JL, Jambazov S.
    Endocrinology; 2006 Sep 30; 147(9):4400-9. PubMed ID: 16763062
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts.
    Conover CA, Khosla S.
    Growth Horm IGF Res; 2003 Dec 30; 13(6):328-35. PubMed ID: 14624766
    [Abstract] [Full Text] [Related]

  • 33. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes.
    Sunic D, McNeil JD, Rayner TE, Andress DL, Belford DA.
    Endocrinology; 1998 May 30; 139(5):2356-62. PubMed ID: 9564845
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion.
    Russo VC, Schütt BS, Andaloro E, Ymer SI, Hoeflich A, Ranke MB, Bach LA, Werther GA.
    Endocrinology; 2005 Oct 30; 146(10):4445-55. PubMed ID: 15994346
    [Abstract] [Full Text] [Related]

  • 37. Testosterone and insulin-like growth factor (IGF) I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts.
    Yoshizawa A, Clemmons DR.
    J Clin Endocrinol Metab; 2000 Apr 30; 85(4):1627-33. PubMed ID: 10770208
    [Abstract] [Full Text] [Related]

  • 38. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells.
    Parker A, Gockerman A, Busby WH, Clemmons DR.
    Endocrinology; 1995 Jun 30; 136(6):2470-6. PubMed ID: 7538463
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Insulin-like growth factor binding protein-4 proteolytic degradation in ovine preovulatory follicles: studies of underlying mechanisms.
    Mazerbourg S, Zapf J, Bar RS, Brigstock DR, Lalou C, Binoux M, Monget P.
    Endocrinology; 1999 Sep 30; 140(9):4175-84. PubMed ID: 10465290
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.